Inhibiting Glycogen Synthase Kinase 3 Suppresses TDP-43-Mediated Neurotoxicity in a Caspase-Dependent Manner

Topic: Brain proteins, microglia and lab models

Abstract Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are progressive neurodegenerative diseases characterised by TAR DNA-binding protein 43 kDa (TDP-43) pathology. We previously showed that deletion of glycogen synthase kinase-3 (GSK3) suppresses TDP-43-mediated motor neuron degeneration in Drosophila . Here, we investigated the potential of GSK3 inhibition to ameliorate TDP-43-mediated toxicity in mammalian neurons. We show that TDP-43 activates GSK3 and promotes caspase-dependent cleavage of TDP-43, generating C-terminal fragments. We determine the functional importance of the N-terminal Asp89 caspase cleavage site in regulating TDP-43 proteostasis in both wild-type and ALS-linked TDP-43 variants and show that GSK3 inhibition selectively reduces truncated TDP-43 species, lowers nuclear TDP-43 levels, and improves neuronal survival. Neuroprotective effects were conserved in primary rodent cortical neurons, primary mouse motor neurons, and human iPSC-derived cortical neurons, highlighting the potentially broad therapeutic potential of GSK3 inhibition. We also find that the GSK3 inhibitor CHIR99021 reduces GSK3 RNA and protein expression and increases GSK3 phosphorylation, indicating novel mechanisms by which it acts to inhibit GSK3 activity. Unexpectedly, an N-terminally truncated variant (TDP-43 N-Del ), originally designed as a negative transfection control, exerted modest toxicity, potentially through retained susceptibility to caspase cleavage. Together, our findings uncover a caspase-mediated mechanism linking GSK3 activity to TDP-43 turnover, localisation, and neurotoxicity, and position GSK3 inhibition as a promising strategy to mitigate TDP-43-driven neurodegeneration in ALS-FTD.

@article{white2026-41546756,
  author  = {White, Matthew A. and Crowley, Leon and Massenzio, Francesca and Li, Xingli and Niblock, Michael and Milani, Sara and Coleman, Michael P. and Barmada, Sami J. and others},
  title   = {{Inhibiting Glycogen Synthase Kinase 3 Suppresses TDP-43-Mediated Neurotoxicity in a Caspase-Dependent Manner}},
  journal = {Molecular Neurobiology},
  year    = {2026},
  doi     = {10.1007/s12035-026-05675-5},
  pmid    = {41546756},
  url     = {https://doi.org/10.1007/s12035-026-05675-5}
}

Key findings

• We previously showed that deletion of glycogen synthase kinase-3 (GSK3) suppresses TDP-43-mediated motor neuron degeneration in Drosophila .
• Together, our findings uncover a caspase-mediated mechanism linking GSK3 activity to TDP-43 turnover, localisation, and neurotoxicity, and position GSK3 inhibition as a promising strategy to mitigate TDP-43-driven neurodegeneration in ALS-FTD.

Why it matters

In laboratory neurons, blocking the enzyme GSK3 reduced harmful forms of the TDP-43 protein and improved neuron survival. This is early cell and animal work, and the authors describe GSK3 inhibition as a promising strategy that still needs testing in people.

Study details

• Evidence strengthLow

Read the original

• DOI: 10.1007/s12035-026-05675-5
• PubMed: 41546756
• Original source →
• Free full text: Molecular Neurobiology →

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Related

Studies in the library that share something with this one. The line above each title says what.

• same condition: frontotemporal dementia TDP-43-associated atrophy in brains with and without frontotemporal lobar degeneration NeuroImage. Clinical · 2022-02-04 · usefulness score 64/100
• same condition: frontotemporal dementia An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degeneration Nature Medicine · 2026-04-15 · usefulness score 63/100
• same condition: frontotemporal dementia Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration Brain : a journal of neurology · 2011-09-01 · usefulness score 57/100
• same condition: frontotemporal dementia Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia The Journal of clinical investigation · 2020-11-01 · usefulness score 57/100
• same condition: frontotemporal dementia Psychiatric symptoms of frontotemporal dementia and subcortical (co-)pathology burden: new insights Brain : a journal of neurology · 2023-01-05 · usefulness score 55/100
• same condition: frontotemporal dementia Ubiquitinated pathological lesions in frontotemporal lobar degeneration contain the TAR DNA-binding protein, TDP-43 Acta neuropathologica · 2007-01-12 · usefulness score 54/100

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 23.

• Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report Brain : a journal of neurology · 2019-06-01 · usefulness score 67/100 · Prevention and risk
• Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis PLoS genetics · 2008-09-19 · usefulness score 65/100 · Lewy body dementia
• TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis Science · 2008-02-28 · usefulness score 64/100 · Disease mechanisms
• Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Science (New York, N.Y.) · 2006-10-01 · usefulness score 62/100 · Lewy body dementia
• Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases Acta neuropathologica · 2007-07-25 · usefulness score 59/100 · How common it is
• Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis Neuron · 2013-08-01 · usefulness score 58/100 · Lewy body dementia
• TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis Biochemical and biophysical research communications · 2006-10-30 · usefulness score 56/100 · Lewy body dementia
• The frontotemporal dementia-motor neuron disease continuum Lancet (London, England) · 2016-03-14 · usefulness score 56/100 · Getting a diagnosis
• TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD Nature neuroscience · 2018-03-19 · usefulness score 56/100 · Brain tissue and pathology
• Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity Proceedings of the National Academy of Sciences of the United States of America · 2009-04-21 · usefulness score 55/100 · Lewy body dementia
• ER-mitochondria associations are regulated by the VAPB-PTPIP51 interaction and are disrupted by ALS/FTD-associated TDP-43 Nature communications · 2014-06-03 · usefulness score 55/100 · Brain tissue and pathology
• Functional and dynamic polymerization of the ALS-linked protein TDP-43 antagonizes its pathologic aggregation Nature communications · 2017-06-29 · usefulness score 55/100 · Lewy body dementia

Related studies in Brain tissue and pathology

• LRRK2 kinase-mediated accumulation of lysosome-associated phospho-Rabs in tauopathies and synucleinopathies Acta neuropathologica · 2025-10-23 · usefulness score 46/100
• Disease-linked TDP-43 hyperphosphorylation suppresses TDP-43 condensation and aggregation The EMBO journal · 2022-02-03 · usefulness score 52/100
• TDP-43-dependent mis-splicing of KCNQ2 triggers intrinsic neuronal hyperexcitability in ALS/FTD Nature Neuroscience · 2025-10-31 · usefulness score 52/100
• A stress-dependent TDP-43 SUMOylation program preserves neuronal function Molecular Neurodegeneration · 2025-03-28 · usefulness score 48/100
• Fluorescence Lifetime-Based FRET Biosensors for Monitoring N Terminal Domain-Dependent Interactions of TDP-43 in Living Cells: A Novel Approach for ALS and FTD Drug Discovery ACS Chemical Neuroscience · 2025-06-10 · usefulness score 38/100
• Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology The Journal of clinical investigation · 2004-07-01 · usefulness score 50/100

Also tagged “tdp-43”

1,150 studies in the library carry the topic tag “tdp-43”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,150 tagged studies.

• Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity Journal of virology · 2001-11-01 · usefulness score 45/100 · Inflammation and the immune system
• Adaptor protein sorting nexin 17 regulates amyloid precursor protein trafficking and processing in the early endosomes The Journal of biological chemistry · 2008-02-13 · usefulness score 46/100 · Risk genes beyond APOE

Studies sharing this one's topic tags

• Lymphoid gene expression supports neuroprotective microglia function Nature · 2025-11-05 · usefulness score 45/100 · shares: tdp-43, transgenic, mice
• Retraction: High-Affinity Naloxone Binding to Filamin A Prevents Mu Opioid Receptor-Gs Coupling / Retraction: Naloxone's Pentapeptide Binding Site on Filamin A Blocks Mu Opioid Receptor-Gs Coupling (among five Wang-authored papers retracted) PLOS ONE · 2022-03-30 · usefulness score 12/100 · shares: tdp-43, transgenic, mice
• Complement and microglia mediate early synapse loss in Alzheimer mouse models Science (New York, N.Y.) · 2016-03-31 · usefulness score 64/100 · shares: tdp-43, transgenic, mice
• Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trial The Lancet Neurology · 2025 · usefulness score 69/100 · shares: tdp-43, transgenic, mice
• Clonal expansion of cytotoxic CD8⁺ T cells in lecanemab-associated ARIA Nature Communications · 2026-01-30 · usefulness score 53/100 · shares: tdp-43, transgenic, mice

Similar studies

• Inhibition of glycogen synthase kinase-3 ameliorates β-amyloid pathology and restores lysosomal acidification and mammalian target of rapamycin activity in the Alzheimer disease mouse model: in vivo and in vitro studies 2013 · Risk genes beyond APOE
• Molecular mechanisms and consequences of TDP-43 phosphorylation in neurodegeneration 2025 · Brain tissue and pathology
• Glycogen synthase kinase-3 signaling in Alzheimer's disease 2020 · Caregiving
• TDP-43 pathology triggers neuroinflammation and cognitive impairment by inducing microglial necroptosis 2026 · Brain tissue and pathology
• G₂C₄ targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in human C9orf72 ALS/FTD induced pluripotent stem cell derived neurons 2023 · Drug development
• Seeded aggregation of TDP-43 induces its loss of function and reveals early pathological signatures 2025 · Brain tissue and pathology

More on Brain tissue and pathology

• A review that covers this ground Vascular dysfunction in the pathogenesis of Alzheimer's disease--A review of endothelium-mediated mechanisms and ensuing vicious circles Neurobiology of disease · 2015-08-23 · usefulness score 46/100
• Newest in this subject Inflammatory biomarker candidates in dementia with Lewy bodies: diagnostic classification, clinical associations, and survival Research Square · 2026-11-01 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject TMEM106B C-Terminal fragment aggregation exacerbates α-synuclein and TDP-43 proteinopathy phenotypes bioRxiv · 2026-10-30 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Brain tissue and pathology →